by GOAI由GOAI生成Share To分享到IDEAYA Biosciences has initiated its Phase 1 clinical trial for IDE034, a bispecific antibody-drug conjugate (ADC) targeting B7H3 and PTK7. The company announced that the ...
网页链接动脉网02-25
by GOAI由GOAI生成Share To分享到IDEAYA Biosciences has initiated its Phase 1 clinical trial for IDE034, a bispecific antibody-drug conjugate (ADC) targeting B7H3 and PTK7. The company announced that the ...
网页链接免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。
